Abstract:The development of hydrogen gas (H2) therapy is highly challenging by reason of low efficiency and suboptimal utilization due to its high diffusibility, nonpolarity, and low solubility of H2 in physiological conditions, which prevent long‐term release and reduce therapeutic efficiency. In light of these challenges, the research offers a novel approach that uses living photosynthetic bacteria, R. sphaeroides, to generate and release H2 for enhanced effective time under the control of NIR light, and also converts NIR light to thermal energy efficiently. This strategy providing a synergistic effect that significantly enhances tumor suppression while protecting normal tissues, which makes it a distinct candidate for anti‐tumor therapies. Hydrogen gas (H2) therapy, recognized for its inherent biosafety, holds significant promise as an anti‐cancer strategy. However, the efficacy of H2 treatment modalities is compromised by their reliance on systemic gas administration or chemical reactions generation, which suffers from low efficiency, poor targeting, and suboptimal utilization. In this study, living therapeutics are employed using photosynthetic bacteria Rhodobacter sphaeroides for in situ H2 production combined with near‐infrared (NIR) mediated photothermal therapy. Living R. sphaeroides exhibits strong absorption in the NIR spectrum, effectively converting light energy into thermal energy while concurrently generating H2. This dual functionality facilitates the targeted induction of tumor cell death and substantially reduces collateral damage to adjacent normal tissues. The findings reveal that integrating hydrogen therapy with photothermal effects, mediated through photosynthetic bacteria, provides a robust, dual‐modality approach that enhances the overall efficacy of tumor treatments. This living therapeutic strategy not only leverages the therapeutic potential of both hydrogen and photothermal therapeutic modalities but also protects healthy tissues, marking a significant advancement in cancer therapy techniques.

Microbial hydrogen "manufactory" for enhanced gas therapy and self-activated immunotherapy via reduced immune escape

Engineering probiotic biohydrogen micro-factories to initiate reductive stress for boosting tumor vulnerability

Prospects of molecular hydrogen in cancer prevention and treatment

Progresses on Molecular Hydrogen as Novel Therapeutic Gas

Hydrogen therapy: recent advances and emerging materials.

Micro/Nanomaterials‐Augmented Hydrogen Therapy

Living Therapeutics for Synergistic Hydrogen‐Photothermal Cancer Treatment by Photosynthetic Bacteria

Hydrogen Gas from Inflammation Treatment to Cancer Therapy

Recent Progress Toward Hydrogen Medicine: Potential of Molecular Hydrogen for Preventive and Therapeutic Applications

New Approaches for Hydrogen Therapy of Various Diseases

Microbial hydrogen economy alleviates colitis by reprogramming colonocyte metabolism and reinforcing intestinal barrier

Progress in the Use of Molecular Hydrogen for Cancer Treatment

Hydrogen Therapy Reverses Cancer‐Associated Fibroblasts Phenotypes and Remodels Stromal Microenvironment to Stimulate Systematic Anti‐Tumor Immunity

Hydrogen Gas Improves Photothermal Therapy of Tumor and Restrains the Relapse of Distant Dormant Tumor.

Hydrogen: A Rising Star in Gas Medicine As a Mitochondria-Targeting Nutrient Via Activating Keap1-Nrf2 Antioxidant System

Engineering micro oxygen factories to slow tumour progression via hyperoxic microenvironments

Conceptual Transition from Molecular to Atomic: Unleashing a New Era in Hydrogen Therapy for Chronic Disease

A platinum nanourchin-based multi-enzymatic platform to disrupt mitochondrial function assisted by modulating the intracellular H 2 O 2 homeostasis.

Hydrogen-water ameliorates radiation-induced gastrointestinal toxicity via MyD88’s effects on the gut microbiota

Molecular Hydrogen and Radiation Protection.

Molecular Hydrogen: Current Knowledge on Mechanism in Alleviating Free Radical Damage and Diseases.